RE:TD
Thanks for posting. Positive comments to calm the nerves. Maybe us bulls are not crazy after all. I do think the downdraft in sp has been related to a sector rotation in to cyclicals and out of tech and growth. And I am comfortable in staying out of that rotation and staying in tech/growth company that is going to help change the face of medicine not just in North America, but across the world. I can live with $400 mill in revenues and EBITDA of $100 mill for the balance of the year.